Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0020672 (
hypothermia
)
17,327
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Bombesin (BN) and structurally related peptides, gastrin-releasing peptide (GRP) and
neuromedin B
(
NMB
), injected into the lateral ventricle produce multiple effects such as
hypothermia
, anorexia and hormone release. In this study, the pharmacological characteristics of BN receptors mediating
hypothermia
in the central nervous system (CNS) were investigated using free-moving male Wistar rats. Intracerebroventricular injections of BN, GRP and
NMB
produced
hypothermia
in a dose-dependent manner. The BN (0.3 microg)-induced effect showed a short latency and a 4-h duration with a potency increased by more than 100 times compared to the
NMB
-induced effect. Pretreatment with [D-Tyr(6)]BN(6-13)methylester, a GRP receptor antagonist, inhibited the BN (0.3 microg)- and
NMB
(7 microg)-induced
hypothermia
. On the other hand, BIM23127, an
NMB
receptor antagonist, did not influence the
hypothermia
. Of the protein kinase C (PKC) inhibitors, chelerythrine, Go6983, staurosporine and GF109203X, the first two partially blocked the BN-induced
hypothermia
. A PKC activator, phorbol-12,13-dibutyrate, decreased the rectal temperature. Genistein (a tyrosine kinase inhibitor), Y-27632 (a Rho kinase inhibitor) and PD98059 (a MAPK inhibitor) tended to suppress the BN-induced
hypothermia
, however, these were not significant. The inhibitory effect of a mixture of the three inhibitors, chelerythrine, genistein and Y-27632, on the BN-induced
hypothermia
was of a similar degree to that of chelerythrine alone. The BN receptor mediating the
hypothermia
seem to be the GRP subtype, and the effect involves activation of PKC.
...
PMID:Pharmacological characteristics of bombesin receptor mediating hypothermia in the central nervous system of rats. 1267 68